Laboratory test availability and user fees in routine HIV care: a global analysis in 42 countries
Clicks: 1
ID: 317229
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #68 of 90 articles by views in Health Affairs Scholar
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Laboratory testing is critical for diagnosis and treatment management for people with HIV, but is costly. When HIV resources are constrained, even before recent disruptions in US funding for the global HIV response, user fees have been used for cost recovery. We describe availability and charging of user fees for routine HIV laboratory testing globally. Methods Routine test availability and charging of user fees were examined via an HIV clinic survey conducted September 2020–March 2021; responses reflected clinical practices in 2019. HIV clinics came from 42 low-, middle-, and high-income countries from the International epidemiology Databases to Evaluate AIDS (IeDEA) global research consortium. Results Across 199 clinics, on-site test availability was generally limited, reflecting constraints in routine test availability across health conditions more broadly. Over 90% of clinics did not report charging of user fees. A higher percentage reporting user fees were from middle-income countries and from countries receiving Global Fund or PEPFAR country support, which may reflect settings with ongoing health funding gaps. Conclusions Availability and user fees for essential HIV-related laboratory tests were limited in 2019. Monitoring user fees may provide insights about how national health systems are responding to steep reductions in global donor funding.
| Reference Key |
openalex_W7164652115
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zhongzhe Pan, Ellen Brazier, Stephany N. Duda, Jeremy Ross, David J. Templeton, Sanjay Pujari, Lauren C. Zalla, Ronald M. Galiwango, Geoffrey Fatti, Gad Murenzi, Gabriela Carriquiry, Henri Chenal, Romanee Chaiwarith, Raynell Lang, Helen Byakwaga, Chido Chinogurei, Peter Ebasone, Carina César, Oliver Ezechi, Aimee Freeman, Lameck Diero, Nicola van Dongen, Patricia Lelo, Sandra Wagner Cardoso, Ephrem Mensah, Kathleen McGinnis, Francesca Odhiambo, Ethel Rambiki, Christella Twizere, Marco Tulio Luque, Armel Poda, April D. Kimmel |
| Journal | Health Affairs Scholar |
| Year | 2026 |
| DOI |
10.1093/haschl/qxag151
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.